Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Critical Care
Published in: Critical Care 1/2020

01-12-2020 | Subarachnoid Hemorrhage | Editorial

Rethinking brain injury after subarachnoid hemorrhage

Authors: Sara Amodio, Pierre Bouzat, Chiara Robba, Fabio Silvio Taccone

Published in: Critical Care | Issue 1/2020

Login to get access

Excerpt

Aneurysmal subarachnoid hemorrhage (aSAH) has an annual incidence of six cases per 100,000 persons, with a high incidence of long-term poor neurological outcome [1, 2]. Several complications may occur after the aneurysm rupture, such as global cerebral ischemia, re-bleeding, medical complications (i.e., infections, anemia and hyponatremia) and the occurrence of secondary brain injury [2]. As such, poor outcome is strongly related to the occurrence of initial (i.e., early brain injury) or delayed events (i.e., delayed cerebral ischemia). However, the nomenclature of these events and their diagnosis/management need to be better specified. …
Literature
1.
Etminan N, Chang H-S, Hackenberg K, de Rooij NK, Vergouwen MDI, Rinkel GJE, et al. Worldwide incidence of aneurysmal subarachnoid hemorrhage according to region, time period, blood pressure, and smoking prevalence in the population: a systematic review and meta-analysis. JAMA Neurol. 2019;76:588–97. CrossRef
2.
Connolly ES, Rabinstein AA, Carhuapoma JR, Derdeyn CP, Dion J, Higashida RT, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage. Stroke. 2012;43:1711–37. CrossRef
3.
Rass V, Helbok R. Early brain injury after poor-grade subarachnoid hemorrhage. Curr Neurol Neurosci Rep. 2019;19:78. CrossRef
4.
Siuta M, Zuckerman SL, Mocco J. Nitric oxide in cerebral vasospasm: theories, measurement, and treatment. Neurol Res Int. 2013;213:972417.
5.
Kusaka G, Ishikawa M, Nanda A, Granger DN, Zhang JH. Signaling pathways for early brain injury after subarachnoid hemorrhage. J Cereb Blood Flow Metab. 2004;24:916–25. CrossRef
6.
Sehba FA, Hou J, Pluta RM, Zhang JH. The importance of early brain injury after subarachnoid hemorrhage. Prog Neurobiol. 2012;97:14–37. CrossRef
7.
Cahill WJ, Calvert JH, Zhang JH. Mechanisms of Early Brain Injury after Subarachnoid Hemorrhage. J Cereb Blood Flow Metab. 2006;26:1341–53. CrossRef
8.
Francoeur CL, Mayer SA. Management of delayed cerebral ischemia after subarachnoid hemorrhage. Crit Care. 2016;20:277. CrossRef
9.
Vergouwen MDI, Vermeulen M, van Gijn J, Rinkel GJE, Wijdicks EF, Muizelaar JP, et al. Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies. Stroke. 2010;41:2391–5. CrossRef
10.
Lin C-L, Dumont AS, Zhang JH, Zuccarello M, Muroi C. Cerebral vasospasm after aneurysmal subarachnoid hemorrhage: mechanism and therapies. Biomed Res Int. 2014;2014:679014. PubMedPubMedCentral
11.
Budohoski KP, Guilfoyle M, Helmy A, Huuskonen T, Czosnyka M, Kirollos R, et al. The pathophysiology and treatment of delayed cerebral ischaemia following subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry. 2014;85:1343–53. CrossRef
12.
Taccone FS, De Oliveira Manoel AL, Robba C, Vincent J-L. Use a “GHOST-CAP” in acute brain injury. Crit Care. 2020;24:89. CrossRef
13.
Wartenberg KE. Update on the management of subarachnoid hemorrhage. Future Neurol. 2013;8:205–24. CrossRef
14.
Wartenberg KE, Schmidt JM, Mayer SA. Multimodality monitoring in neurocritical care. Crit Care Clin. 2007;23:507–38. CrossRef
15.
Schulz MK, Wang LP, Tange M, Bjerre P. Cerebral microdialysis monitoring: determination of normal and ischemic cerebral metabolisms in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg. 2000;93:808–14. CrossRef
Metadata
Title
Rethinking brain injury after subarachnoid hemorrhage
Authors
Sara Amodio
Pierre Bouzat
Chiara Robba
Fabio Silvio Taccone
Publication date
01-12-2020
Publisher
BioMed Central
Published in
Critical Care / Issue 1/2020
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/s13054-020-03342-2

Other articles of this Issue 1/2020

Critical Care 1/2020 Go to the issue

Research

Circulating bioactive adrenomedullin as a marker of sepsis, septic shock and critical illness

Editorial

The challenge of ventilator-associated pneumonia diagnosis in COVID-19 patients

Research Letter

COVID-19 patients exhibit less pronounced immune suppression compared with bacterial septic shock patients

Commentary

Shining a light on the evidence for hydroxychloroquine in SARS-CoV-2

Research

Monocytic HLA-DR expression kinetics in septic shock patients with different pathogens, sites of infection and adverse outcomes

Research

Efficacy of ultrasound-guided technique for radial artery catheterization in pediatric populations: a systematic review and meta-analysis of randomized controlled trials